Alps Advisors Inc. Acquires 7,686 Shares of AMERISAFE, Inc. (NASDAQ:AMSF)

Alps Advisors Inc. increased its position in shares of AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) by 7.8% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 106,697 shares of the insurance provider's stock after buying an additional 7,686 shares during the period. Alps Advisors Inc. owned 0.56% of AMERISAFE worth $5,607,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of AMSF. GAMMA Investing LLC grew its holdings in AMERISAFE by 19.1% during the 1st quarter. GAMMA Investing LLC now owns 1,600 shares of the insurance provider's stock worth $84,000 after acquiring an additional 257 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in AMERISAFE by 3.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,842 shares of the insurance provider's stock worth $559,000 after acquiring an additional 357 shares during the period. Bank of Montreal Can grew its holdings in AMERISAFE by 4.6% during the 4th quarter. Bank of Montreal Can now owns 9,375 shares of the insurance provider's stock worth $483,000 after acquiring an additional 410 shares during the period. MetLife Investment Management LLC grew its holdings in AMERISAFE by 6.1% during the 4th quarter. MetLife Investment Management LLC now owns 11,692 shares of the insurance provider's stock worth $603,000 after acquiring an additional 669 shares during the period. Finally, WINTON GROUP Ltd grew its holdings in AMERISAFE by 3.3% during the 4th quarter. WINTON GROUP Ltd now owns 21,859 shares of the insurance provider's stock worth $1,127,000 after acquiring an additional 690 shares during the period. Institutional investors and hedge funds own 97.41% of the company's stock.

Analyst Ratings Changes

Separately, JMP Securities restated a "market outperform" rating and issued a $65.00 target price on shares of AMERISAFE in a research note on Wednesday, April 30th.

AMERISAFE Price Performance

Shares of AMSF opened at $43.18 on Friday. The stock has a 50-day moving average of $45.50 and a 200-day moving average of $48.71. The company has a market cap of $822.58 million, a PE ratio of 17.41 and a beta of 0.40. AMERISAFE, Inc. has a one year low of $42.48 and a one year high of $60.24.

AMERISAFE (NASDAQ:AMSF - Get Free Report) last issued its earnings results on Tuesday, April 29th. The insurance provider reported $0.60 EPS for the quarter, beating the consensus estimate of $0.59 by $0.01. The company had revenue of $83.78 million during the quarter, compared to the consensus estimate of $76.66 million. AMERISAFE had a return on equity of 16.41% and a net margin of 15.76%. Analysts expect that AMERISAFE, Inc. will post 2.45 EPS for the current fiscal year.

AMERISAFE Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 13th were paid a $0.39 dividend. The ex-dividend date was Friday, June 13th. This represents a $1.56 annualized dividend and a dividend yield of 3.61%. AMERISAFE's dividend payout ratio is presently 62.90%.

About AMERISAFE

AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.